Huge Rs 55 Dividend Sparks Bullish Surge! Record Date Revised To April 17 – Fresh Rally Brewing?

After a demerger in June 2024, Sanofi India Limited became Sanofi Consumer Healthcare India Limited (SCHIL), one of India's top consumer healthcare companies. Allegra, Combiflam, DePURA, and Avil are a few of SCHIL's well-known brand names. After the Board changed the record date for Sanofi Consumer Healthcare India's upcoming dividend of Rs 55 per share from Monday, April 28, 2025 to Thursday, April 17, 2025, the company's shares ended the last trading session on Friday 1.28 percent higher on the NSE at Rs 4,948.75 per share with a market cap of Rs 11,397.28 Cr.

Sanofi Consumer Healthcare India Dividend

"This has reference to our letter dated 4th March 2025 communicating the Record Date as Monday, 28th April 2025 for the purpose of payment of final dividend of Rs. 55/- per equity share of the face value of Rs. 10/- each, subject to the approval of shareholders at the ensuing Second Annual General Meeting of the Company, for the year ended 31st December 2024. Pursuant to this letter, Members of the Company are hereby informed that, the Record Date for the purpose of payment of final dividend is now being modified from Monday, 28th April 2025 to Thursday, 17th April 2025," said Sanofi Consumer Healthcare India in a stock exchange filing.

"This change in Record Date is to ensure compliance with the Regulation 26(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in relation to the ongoing open offer by Opal Bidco SAS (Acquirer) together with Clayton, Dubilier & Rice Fund XII, L.P. (Person Acting in Concert with the Acquirer) to the public shareholders of the Company. For the avoidance of doubt, it is clarified that, there is no change in the date of Second Annual General Meeting of the Company, which is scheduled to be held on Monday, 5th May 2025, as intimated to you by our letter dated 27th March 2025," Sanofi Consumer Healthcare India further informed stock exchanges.

Sanofi Consumer Healthcare India Dividend Payment Date

"Payment of dividend, as recommended by the Board of Directors, if approved at the meeting, will be made on or after Tuesday, 20th May 2025, to those members whose names are on the Company's Register of Members on Thursday, 17th April 2025, and those whose names appear as Beneficial Owners at the close of business hours on Thursday, 17th April 2025, as per the details to be furnished by the Depositories, viz. NSDL and Central Depository Services (India) Limited (CDSL) for this purpose," said Sanofi Consumer Healthcare India in a statement.

Sanofi Consumer Healthcare India News

"Pursuant to Regulation 26(7) of the Takeover Regulations, as amended, please find enclosed herewith the written reasoned recommendations of the Committee of the Independent Directors, at its meeting held on 10 April 2025, on the open offer by Opal Bidco SAS ("Acquirer") together with Clayton, Dubilier & Rice Fund XII, L.P., (a person acting in concert with the Acquirer) to the public shareholders of Sanofi Consumer Healthcare India Limited for acquiring up to 59,87,962 (Fifty Nine Lakh Eighty Seven Thousand Nine Hundred and Sixty Two) fully paid-up equity shares of face value of Rs. 10 (Indian Rupees Ten only) each, representing 26% (Twenty Six Percent) of the fully diluted voting share capital of Sanofi Consumer Healthcare India Limited at an offer price of Rs. 4,982.05 (Indian Rupees Four Thousand Nine Hundred Eighty Two Point Zero Five) per equity share," Sanofi Consumer Healthcare India said in a stock exchange filing on 10th April 2025.

Sanofi Consumer Healthcare India Share Price Target

"The technical chart of SANOFICONR shows a recent bullish breakout above the consolidation zone, with the stock surging past major moving averages such as the 20-day, 50-day, and 200-day EMAs. The closing price of 4943.20 represents a +1.17% gain for the day, aided by stronger activity. This breakout follows an extended sideways phase and indicates new bullish momentum. The RSI has risen to 65, entering the overbought area but still with potential for further gains before any signs of exhaustion," said Mandar Bhojane - Equity Research Analyst at Choice Broking.

"Given that 5020 is a psychological resistance level, the price action suggests the possible start of a fresh upswing. In the short term, a good closure above that level might create space towards 5200-5300. The recent breakout area between 4815 and 4780 (100 and 50 EMA) is now a solid support cluster on the downside," the analyst further recommended.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.